Long noncoding RNA HITT coordinates with RGS2 to inhibit PD-L1 translation in T cell immunity-Reference-Cited by-同舟云学术

Long noncoding RNA HITT coordinates with RGS2 to inhibit PD-L1 translation in T cell immunity

Published:2023-06-01 Issue:11 Volume:133 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Lin Qingyu,Liu Tong,Wang Xingwen,Hou Guixue^ORCID,Xiang Zhiyuan,Zhang Wenxin,Zheng Shanliang,Zhao Dong^ORCID,Leng Qibin^ORCID,Zhang Xiaoshi,Lu Minqiao,Guan Tianqi,Liu Hao,Hu Ying^ORCID

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/162951/files/pdf

Reference41 articles.

1. The Basis of Oncoimmunology

2. Adaptive Immune Resistance: How Cancer Protects from Immune Attack

3. PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: mechanisms, response biomarkers, and combinations;Zou;Sci Transl Med,2016

4. Regulation and Function of the PD-L1 Checkpoint

5. Clinical benefit of neoadjuvant anti-PD-1/PD-L1 utilization among different tumors;Li;MedComm (2020),2021

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New mechanism of LncRNA: In addition to act as a ceRNA;Non-coding RNA Research;2024-12

2. Exploring the promise of regulator of G Protein Signaling 20: insights into potential mechanisms and prospects across solid cancers and hematological malignancies;Cancer Cell International;2024-09-03

3. Mechanism research of non‐coding RNA in immune checkpoint inhibitors therapy;Cancer Science;2024-08-13

4. Current concepts of the crosstalk between lncRNA and E2F1: shedding light on the cancer therapy;Frontiers in Pharmacology;2024-07-25

5. PD-L1 at the crossroad between RNA metabolism and immunosuppression;Trends in Molecular Medicine;2024-07